Gram-Negative Sepsis Is Critical for Survival to Neonatal TRIF-Dependent Innate Immune Activation

Current evidence suggests that neonatal immunity is functionally distinct from adults. Although TLR signaling through the adaptor protein, MyD88, has been shown to be critical for survival to sepsis in adults, little is known about the role of MyD88 or TRIF in neonatal sepsis. We demonstrate that TRIF 2 / 2 but not MyD88 2 / 2 neonates are highly susceptible to Escherichia coli peritonitis and bacteremia. This was associated with decreased innate immune recruitment and function. Importantly, we found that the reverse was true in adults that MyD88 2 / 2 but not TRIF 2 / 2 or wild-type adults are susceptible to E. coli peritonitis and bacter-emia. In addition, we demonstrate that TRIF but not MyD88 signaling is critical for the TLR4 protective adjuvant effect we have previously demonstrated. These data suggest a differential requirement for the survival of neonates versus adults to Gram-negative infection, and that modulation of TRIF in neonates can be used to augment survival to neonatal sepsis. The Journal of Immunology , 2015, 194: 000–000. In those cases where normality failed, either a Mann–Whitney U test using the Hodges–Lehmann estimator or a Kruskal–Wallis ANOVA on ranks was also performed. In the latter case, a Dunn’s post hoc analysis was performed. However, nonparametric tests are not without their limits.

[1]  P. Trieu-Cuot,et al.  TLR2-Induced IL-10 Production Impairs Neutrophil Recruitment to Infected Tissues during Neonatal Bacterial Sepsis , 2013, The Journal of Immunology.

[2]  L. Moldawer,et al.  Role of Innate Immunity in Neonatal Infection , 2013, American Journal of Perinatology.

[3]  K. Schesser,et al.  Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity , 2011, The Journal of experimental medicine.

[4]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[5]  L. Moldawer,et al.  Neutrophil Mobilization from the Bone Marrow during Polymicrobial Sepsis Is Dependent on CXCL12 Signaling , 2011, The Journal of Immunology.

[6]  B. Poindexter,et al.  Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues , 2011, Pediatrics.

[7]  L. Moldawer,et al.  Critical Role for CXC Ligand 10/CXC Receptor 3 Signaling in the Murine Neonatal Response to Sepsis , 2011, Infection and Immunity.

[8]  L. Moldawer,et al.  Sepsis Induces Early Alterations in Innate Immunity That Impact Mortality to Secondary Infection , 2011, The Journal of Immunology.

[9]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[10]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[11]  G. Garlet,et al.  The essential role of toll like receptor-4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. , 2010, Journal of clinical periodontology.

[12]  A. Weyrich,et al.  Comment on Chapter 5 , 1999 .

[13]  Sung-Moo Park,et al.  Innate Immunity Mediated by MyD88 Signal Is Not Essential for Induction of Lipopolysaccharide-Specific B Cell Responses but Is Indispensable for Protection against Salmonella enterica serovar Typhimurium infection1 , 2009, The Journal of Immunology.

[14]  T. van der Poll,et al.  MyD88 Dependent Signaling Contributes to Protective Host Defense against Burkholderia pseudomallei , 2008, PloS one.

[15]  L. Moldawer,et al.  Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. , 2008, Blood.

[16]  R. Baltimore,et al.  Changing Patterns in Neonatal Escherichia coli Sepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic Prophylaxis , 2008, Pediatrics.

[17]  R. Hotchkiss,et al.  Deletion of MyD88 markedly attenuates sepsis‐induced T and B lymphocyte apoptosis but worsens survival , 2008, Journal of leukocyte biology.

[18]  A. Lapillonne,et al.  Outcome and prognostic factors in neonates with septic shock* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  L. Moldawer,et al.  INCREASED MORTALITY AND ALTERED IMMUNITY IN NEONATAL SEPSIS PRODUCED BY GENERALIZED PERITONITIS , 2007, Shock.

[20]  D. Hackam,et al.  Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis. , 2007, Journal of pediatric surgery.

[21]  J. Pober,et al.  Heparin Displaces Interferon-&ggr;–Inducible Chemokines (IP-10, I-TAC, and Mig) Sequestered in the Vasculature and Inhibits the Transendothelial Migration and Arterial Recruitment of T Cells , 2006, Circulation.

[22]  S. Cousens,et al.  Estimating the causes of 4 million neonatal deaths in the year 2000. , 2006, International journal of epidemiology.

[23]  P. Engel,et al.  Cutting Edge: MyD88 Controls Phagocyte NADPH Oxidase Function and Killing of Gram-Negative Bacteria1 , 2005, The Journal of Immunology.

[24]  H. Redmond,et al.  Bacterial Lipoprotein Induces Resistance to Gram-Negative Sepsis in TLR4-Deficient Mice via Enhanced Bacterial Clearance1 , 2005, The Journal of Immunology.

[25]  A. Schuchat,et al.  Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 , 2004, The Pediatric infectious disease journal.

[26]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[27]  M. Golightly,et al.  In vivo Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Phagocytic Function and Oxidative Burst Activity in Septic Neutropenic Neonates , 2004, Neonatology.

[28]  A. Luster,et al.  CXCR3 and Heparin Binding Sites of the Chemokine IP-10 (CXCL10)* , 2003, The Journal of Biological Chemistry.

[29]  Gilles Clermont,et al.  The epidemiology of severe sepsis in children in the United States. , 2003, American journal of respiratory and critical care medicine.

[30]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[31]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[32]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[33]  P. Trieu-Cuot,et al.  during Neonatal Bacterial Sepsis Neutrophil Recruitment to Infected Tissues TLR2-Induced IL-10 Production Impairs , 2013 .